Hormonal imbalance in patients with chronic renal failure in the pre-dialysis and dialysis periods (part 1)
The review describes the problem of studying progressive changes of hormones concentrations (parathyroid hormone, insulin, somatotropin, prolactin) in patients with chronic renal failure on the pre-dialysis and dialysis stages. The pathogenetic relationships between kidney function deterioration and...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2023-03-01
|
| Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
| Subjects: | |
| Online Access: | https://iej.zaslavsky.com.ua/index.php/journal/article/view/1243 |
| _version_ | 1797811220797980672 |
|---|---|
| author | I.P. Katerenchuk S.T. Rustamyan V.V. Talash T.I. Yarmola |
| author_facet | I.P. Katerenchuk S.T. Rustamyan V.V. Talash T.I. Yarmola |
| author_sort | I.P. Katerenchuk |
| collection | DOAJ |
| description | The review describes the problem of studying progressive changes of hormones concentrations (parathyroid hormone, insulin, somatotropin, prolactin) in patients with chronic renal failure on the pre-dialysis and dialysis stages. The pathogenetic relationships between kidney function deterioration and hormone concentrations as well as changes of their biological effects were evaluated. Parathyroid hormone is considered as an uraemic toxin, since its concentration in the blood begins to increase when the glomerular filtration rate decreases below 50 ml/min. All stages of chronic kidney disease are accompanied by disorders of calcium-phosphorus metabolism. Prolonged excess of parathyroid hormone leads to bone loss and to the progression to secondary hyperparathyroidism that is a frequent complication in patients with the later stages of chronic renal failure and, especially, in those on dialysis treatment. The elevation of insulin level in chronic renal failure is the consequence of progressive decrease in glomerular filtration rate and insulin excretion by proximal tubules. So, it results in insulin half-life prolongation. Long-term dialysis therapy eliminates factors that reduce the degradation of insulin by extrarenal tissues, which results in an improvement of their insulin sensitivity. Experimental and clinical studies have shown that an excess of somatotropin can adversely affect the kidneys that leads to glomerular hyperfiltration and the progression to glomerulosclerosis. The risk of possible side effects on kidneys should be taken into account when prescribing recombinant human insulin-like growth factor. The prolactin concentration is usually increased in chronic kidney disease due to reduced clearance and increased secretion. Hyperprolactinemia manifests as galactorrhea and hypogonadism. Dialysis therapy can’t normalize the increased concentration of prolactin. Modern options for pathogenetic treatment of endocrine disorders in patients with chronic renal failure are outlined in this article. It was found that kidneys play an important role in regulating hormones concentrations in the blood. Endocrine disorders are one of the most important components of the uraemic syndrome, which requires further clinical studies, aimed on the searching of better treatment strategies and prevention of hormonal imbalance on the pre-dialysis and dialysis stages of chronic kidney disease. |
| first_indexed | 2024-03-13T07:19:26Z |
| format | Article |
| id | doaj.art-b104eb33780f4d6e91454d33698f9535 |
| institution | Directory Open Access Journal |
| issn | 2224-0721 2307-1427 |
| language | English |
| last_indexed | 2024-03-13T07:19:26Z |
| publishDate | 2023-03-01 |
| publisher | Zaslavsky O.Yu. |
| record_format | Article |
| series | Mìžnarodnij Endokrinologìčnij Žurnal |
| spelling | doaj.art-b104eb33780f4d6e91454d33698f95352023-06-04T19:49:26ZengZaslavsky O.Yu.Mìžnarodnij Endokrinologìčnij Žurnal2224-07212307-14272023-03-01191657110.22141/2224-0721.19.1.2023.12431241Hormonal imbalance in patients with chronic renal failure in the pre-dialysis and dialysis periods (part 1)I.P. Katerenchuk0https://orcid.org/0000-0003-3765-4895S.T. Rustamyan1https://orcid.org/0000-0003-4348-6365V.V. Talash2https://orcid.org/0000-0002-5700-557XT.I. Yarmola3https://orcid.org/0000-0002-7428-0223Poltava State Medical University, Poltava, UkrainePoltava State Medical University, Poltava, UkrainePoltava State Medical University, Poltava, UkrainePoltava State Medical University, Poltava, UkraineThe review describes the problem of studying progressive changes of hormones concentrations (parathyroid hormone, insulin, somatotropin, prolactin) in patients with chronic renal failure on the pre-dialysis and dialysis stages. The pathogenetic relationships between kidney function deterioration and hormone concentrations as well as changes of their biological effects were evaluated. Parathyroid hormone is considered as an uraemic toxin, since its concentration in the blood begins to increase when the glomerular filtration rate decreases below 50 ml/min. All stages of chronic kidney disease are accompanied by disorders of calcium-phosphorus metabolism. Prolonged excess of parathyroid hormone leads to bone loss and to the progression to secondary hyperparathyroidism that is a frequent complication in patients with the later stages of chronic renal failure and, especially, in those on dialysis treatment. The elevation of insulin level in chronic renal failure is the consequence of progressive decrease in glomerular filtration rate and insulin excretion by proximal tubules. So, it results in insulin half-life prolongation. Long-term dialysis therapy eliminates factors that reduce the degradation of insulin by extrarenal tissues, which results in an improvement of their insulin sensitivity. Experimental and clinical studies have shown that an excess of somatotropin can adversely affect the kidneys that leads to glomerular hyperfiltration and the progression to glomerulosclerosis. The risk of possible side effects on kidneys should be taken into account when prescribing recombinant human insulin-like growth factor. The prolactin concentration is usually increased in chronic kidney disease due to reduced clearance and increased secretion. Hyperprolactinemia manifests as galactorrhea and hypogonadism. Dialysis therapy can’t normalize the increased concentration of prolactin. Modern options for pathogenetic treatment of endocrine disorders in patients with chronic renal failure are outlined in this article. It was found that kidneys play an important role in regulating hormones concentrations in the blood. Endocrine disorders are one of the most important components of the uraemic syndrome, which requires further clinical studies, aimed on the searching of better treatment strategies and prevention of hormonal imbalance on the pre-dialysis and dialysis stages of chronic kidney disease.https://iej.zaslavsky.com.ua/index.php/journal/article/view/1243reviewchronic renal failuredialysisparathyroid hormoneinsulingrowth hormoneprolactin |
| spellingShingle | I.P. Katerenchuk S.T. Rustamyan V.V. Talash T.I. Yarmola Hormonal imbalance in patients with chronic renal failure in the pre-dialysis and dialysis periods (part 1) Mìžnarodnij Endokrinologìčnij Žurnal review chronic renal failure dialysis parathyroid hormone insulin growth hormone prolactin |
| title | Hormonal imbalance in patients with chronic renal failure in the pre-dialysis and dialysis periods (part 1) |
| title_full | Hormonal imbalance in patients with chronic renal failure in the pre-dialysis and dialysis periods (part 1) |
| title_fullStr | Hormonal imbalance in patients with chronic renal failure in the pre-dialysis and dialysis periods (part 1) |
| title_full_unstemmed | Hormonal imbalance in patients with chronic renal failure in the pre-dialysis and dialysis periods (part 1) |
| title_short | Hormonal imbalance in patients with chronic renal failure in the pre-dialysis and dialysis periods (part 1) |
| title_sort | hormonal imbalance in patients with chronic renal failure in the pre dialysis and dialysis periods part 1 |
| topic | review chronic renal failure dialysis parathyroid hormone insulin growth hormone prolactin |
| url | https://iej.zaslavsky.com.ua/index.php/journal/article/view/1243 |
| work_keys_str_mv | AT ipkaterenchuk hormonalimbalanceinpatientswithchronicrenalfailureinthepredialysisanddialysisperiodspart1 AT strustamyan hormonalimbalanceinpatientswithchronicrenalfailureinthepredialysisanddialysisperiodspart1 AT vvtalash hormonalimbalanceinpatientswithchronicrenalfailureinthepredialysisanddialysisperiodspart1 AT tiyarmola hormonalimbalanceinpatientswithchronicrenalfailureinthepredialysisanddialysisperiodspart1 |